A- A A+

Ta-Chung Chao (趙大中)

  • 2875-7270
Ta-Chung Chao(趙大中)

簡介

學歷
  1. 國立陽明大學 臨床醫學研究所 博士
  2. 臺北醫學大學 醫學系 醫學士
經歷 現職:
  1. - 迄今 臺北榮民總醫院 腫瘤醫學部 藥物治療科 主治醫師
  2. - 迄今 台灣癌症臨床研究發展基金會 執行長
  3. - 迄今 台灣癌症安寧緩和醫學會 秘書長
  4. - 迄今 國防醫學院 醫學系 臨床副教授
  5. - 迄今 國立陽明大學 醫學系 內科學科 助理教授
經歷:
  1. - 臺北榮民總醫院 內科部 血液腫瘤科 主治醫師
  2. - 臺北榮民總醫院 內科部 腫瘤科 住院總醫師
醫療專長
  1. 腫瘤內科學、乳癌、肺癌、大腸直腸癌、惡性肉瘤、泌尿系統癌症、血液惡性疾病
證照
  1. ECFMG/USMLE、血液病專科醫師與指導醫師、腫瘤內科專科醫師、血液病專科醫師、乳房專科醫師、癌症安寧緩和醫學專科醫師、血液及骨髓移植專科醫師、內科專科醫師

著作

PubMed

  1. Cortes J*, Perez-Garcia J, Levy C, Gómez Pardo P, Bourgeois H, Spazzapan S, Martínez-Jañez N, Chao TC, Espié M, Nabholtz JM, Gonzàlez Farré X, Beliakouski V, Román García J, Holgado E, Campone M.  Open-Label Randomised Phase III Trial of Vinflunine Versus an Alkylating Agent in Patients with Heavily Pretreated Metastatic Breast Cancer. Ann Oncol 2018 Apr; 29(4): 881-7. Epub 2018 Feb. (IF: 11.855; Oncology 10/217)

  2. Rau KM, Ou-Yang F, Chao TC, Kuo YL, Cheng TF, Chao TY, Chen DR, Tzeng YD, Wang BW, Liu CY, Hu MH, Lu YC, Ou WJ, Kuo CH, Chuang CH, Kan JY, Chen FM*, Hou MF*.  Effect of Eribulin on Patients with Metastatic Breast Cancer: Multicenter Retrospective Observational Study in Taiwan. Breast Cancer Res Treat 2018 Aug; 170(3): 583-91. Epub 2018 Apr. (IF: 3.626; Oncology 82/217)

  3. Chou YS, Liu CY, Chang YH, King KL, Chen PC, Pan CC, Shen SH, Liu YM, Lin AT, Chen KK, Shyr YM, Lee RC, Chao TC, Yang MH, Chan CH, You JY, Yen CC.  Prognostic Factors of Primary Resected Retroperitoneal Soft Tissue Sarcoma: Analysis From A Single Asian Tertiary Center and External Validation of Gronchi's Nomogram. J Surg Oncol 2016 Mar; 113(4): 355-60. (IF: 3.151; Surgery 26/200; Oncology 91/213)

  4. Chen PM, Chu PY, Tung SL, Liu CY, Tsai YF, Lin YS, Wang WL, Wang YL, Lien PJ, Chao TC, Tseng LM*.  Overexpression of Phosphoprotein Phosphatase 2A Predicts Worse Prognosis in Patients with Breast Cancer: A 15-Year Follow-Up. Hum Pathol 2017 Aug; 66(): 93-100. Epub 2017 Jun. (IF: 3.014; Pathology 18/79)

  5. Sung PL, Wen KC, Chen YJ, Chao TC, Tsai YF, Tseng LM, Qiu JT, Chao KC, Wu HH, Chuang CM, Wang PH*, Huang CF*.  The Frequency of Cancer Predisposition Gene Mutations in Hereditary Breast and Ovarian Cancer Patients in Taiwan: From BRCA1/2 to Multi-Gene Panels. PLoS One 2017 Sep; 12(9): e0185615. (IF: 2.806; Multidisciplinary Sciences 15/64)

  6. Lee CY, Yen CC, Yen HJ, Shiau CY, Chao TC, Wu PK, Chen CF, Chen PC, Wu HT, Chiou HJ, Chen CC, Hung GY, Chen WM.  Outcomes of 50 Patients with Ewing Sarcoma Family of Tumors Treated At A Single Institution in Taiwan. Medicine (Baltimore) 2016 May; 95(22): e3830. (IF: 2.133; Medicine, General & Internal 40/155)

  7. Liang SY, Chao TC, Tseng LM, Tsay SL, Lin KC, Tung HH.  Symptom-Management Self-Efficacy Mediates the Effects of Symptom Distress on the Quality of Life Among Taiwanese Oncology Outpatients with Breast Cancer. Cancer Nurs 2016 Jan-Feb; 39(1): 67-73. (IF: 2.017; Nursing 9/116; Oncology 154/213)

  8. Ho KY*, Ahn JS, Calimag MM, Chao TC, Kim YC, Moon H, Tho LM, Xia ZJ, You D.  Inadequate Treatment Practices for Pain Relief and Adverse Event Management in Cancer Patients Across 10 Countries/Regions in Asia: a Call for Greater Efforts to Improve Standards for Patient Care. Asia Pac J Clin Oncol 2018 Jun; 14(3): 159-66. Epub 2017 Jul. (IF: 1.959; Oncology 159/217)

  9. Chen JS*, Yeh CN, Cheng CT, Yen CC*, Chen YY, Huang SC, Chiang KC, Yeh TS, Chen SC, Chao TC, Yang MH, Chao Y.  Role of PLK1 Signaling Pathway Genes in Gastrointestinal Stromal Tumors. Oncol Lett 2018 Sep; 16(3): 3070-82. Epub 2018 Jun. (IF: 1.664; Oncology 193/222)

  10. Chung SY, Chen YH, Lin PR, Chao TC, Su JC, Shiau CW, Su Y*.  Two Novel SHP-1 Agonists, SC-43 and SC-78, are more Potent than Regorafenib in Suppressing the in Vitro Stemness of Human Colorectal Cancer Cells. Cell Death Discov 2018 Aug. [Epub ahead of print] (IF: 0.000; ; ; ; ; )